Adam M. Masin has, over the past 20 years, successfully managed and litigated dozens of pharmaceutical and medical device product liability litigations for leading pharmaceutical companies and medical device manufacturers and health care institutions. Clients seek Adam’s counsel on product liability, medical negligence and commercial litigation, and he is particularly experienced in multidistrict litigations (MDLs), consolidated state actions and individual lawsuits involving complex medical issues. He also advises companies on FDA issues, product risk management and investigations. Adam is able to draw on a wealth of contacts in Europe and Brazil to handle cross-border issues.
Adam handles complex medical-related litigation for Connecticut’s world-renowned university-affiliated health care system. His experience includes litigations involving drugs, devices, nutritional supplements, probiotics, neonatology, cardiology, oncology, urogynecology, orthopedics, mycology, hematology, neuropsychology, internal medicine, primary care and a range of other medical specialties. Adam serves on the Board of Directors of the NEC Society, the leading 501(c)(3) dedicated to the neonatal disease necrotizing enterocolitis
Adam has handled appeals in the Second Circuit and Sixth Circuit, and appeared in numerous federal and state courts. He served as judicial intern for U.S. Magistrate Hon. Arlene R. Lindsay in the Eastern District of New York.
- Obtained complete defense victory as trial counsel for Yale New Haven Hospital in a product liability lawsuit involving the use of probiotics to prevent necrotizing enterocolitis.
- Prepared expert medical witnesses for deposition and trial testimony in the Hip Implant Products MDL.
- Handled all case-specific discovery in one of four MDL Bellwether trial cases for a female pelvic mesh manufacturer. Adam has handled case-specific discovery in dozens of individual pelvic mesh lawsuits.
- Obtained a favorable eight-figure settlement on behalf of an international pharmaceutical manufacturer in a commercial litigation involving the U.S. marketing of their branded drug.
- Obtained complete trial court and Second Circuit victories in Megna v. Food and Drug Administration, a product liability lawsuit involving Interferon.
- Obtained complete trial court and Sixth Circuit victories in a diet drug lawsuit, Montgomery v. Wyeth, based on the Tennessee statute of repose, and successfully defended a collateral attack on the judgment in the MDL Court.
- Obtained complete trial court and appellate victories in Nelson v. Wyeth, the first hormone therapy case to go to trial in the Philadelphia Court of Common Pleas.
- Obtained complete trial court and appellate victories in Cochran v. Wyeth, setting Pennsylvania precedent that a failure to warn claim cannot be based on injuries the plaintiff did not have.
- Briefed Wyeth’s summary judgment motion in Bailey v. Wyeth, which held Wyeth’s hormone therapy warnings to be adequate as a matter of New Jersey law and resulted in dismissal of hundreds of cases.
Fordham University School of Law, Lawrence J. McKay prize for Excellence in Oral Advocacy
Awards Methodology (www.drinkerbiddle.com/content/awards)
- New York
- Fordham University School of Law, J.D., 2000, Fordham International Law Journal; National Moot Court Team
- University of Wisconsin - Madison, B.A., 1995
- U.S. District Court, District of Connecticut
- U.S. District Court, Southern District of New York
- American Bar Association, Section of Litigation
- Connecticut Bar Association
- Hartford County Bar Association
- DRI: The Voice of the Defense Bar
- Brazilian-American Chamber of Commerce
- NEC Society Board of Directors (2019)
- Just the Beginning, Pipeline Organization Summer Legal Institute Moot Court